We are live on
!
Find out more
SO
STRS Ohio Portfolio holdings
AUM
$25.2B
1-Year Est. Return
30.31%
This Fund
S&P 500
This Quarter
Est. Return
+23.23%
1 Year Est. Return
+30.31%
3 Year Est. Return
+102.28%
5 Year Est. Return
+135.19%
10 Year Est. Return
+493.48%
AUM
$22.9B
AUM Growth
+$3.89B
(+20%)
Cap. Flow
-$22.2M
Cap. Flow
% of AUM
-0.1%
Top 10 Holdings %
Top 10 Hldgs %
23.15%
Holding
2,333
New
311
Increased
958
Reduced
613
Closed
176
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Golub Capital BDC
GBDC
|
+$74.9M |
| 2 |
Keysight
KEYS
|
+$52.1M |
| 3 |
Merck
MRK
|
+$40.9M |
| 4 |
AbbVie
ABBV
|
+$38.6M |
| 5 |
BioMarin Pharmaceuticals
BMRN
|
+$37.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$104M |
| 2 |
Match Group
MTCH
|
+$48.9M |
| 3 |
TransDigm Group
TDG
|
+$43.4M |
| 4 |
Stryker
SYK
|
+$43.1M |
| 5 |
Johnson & Johnson
JNJ
|
+$42.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.57% |
| 2 | Financials | 14.31% |
| 3 | Healthcare | 13.92% |
| 4 | Consumer Discretionary | 9.62% |
| 5 | Communication Services | 8.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GBT
1151
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $619K | ﹤0.01% |
9,812
+2,512
| +34% | +$172K |
|
1152
Innospec
IOSP
$2.09B
| $618K | ﹤0.01% |
8,000
-3,200
| -29% | -$234K |
|
1153
Champion Homes
SKY
$4.48B
| $618K | ﹤0.01% |
25,400
-5,300
| -17% | -$110K |
|
1154
Universal Electronics
UEIC
$57.2M
| $618K | ﹤0.01% |
13,200
| – | – |
|
1155
Copart
CPRT
$25.9B
| $617K | ﹤0.01% |
29,680
-40,304
| -58% | -$809K |
|
1156
Allogene Therapeutics
ALLO
$601M
| $616K | ﹤0.01% |
+14,400
| New | +$521K |
|
1157
CorVel
CRVL
$3.05B
| $616K | ﹤0.01% |
26,100
-51,600
| -66% | -$1.02M |
|
|
SHYF
1158
DELISTED
The Shyft Group
SHYF
| $616K | ﹤0.01% |
36,600
-3,000
| -8% | -$45.3K |
|
|
ECOM
1159
DELISTED
CHANNELADVISOR CORPORATION
ECOM
| $616K | ﹤0.01% |
38,900
-13,900
| -26% | -$161K |
|
1160
BlackLine
BL
$1.69B
| $613K | ﹤0.01% |
7,400
+4,700
| +174% | +$314K |
|
|
CAF
1161
Morgan Stanley China A Share Fund
CAF
$334M
| $613K | ﹤0.01% |
31,442
+28,931
| +1,152% | +$541K |
|
1162
Coca-Cola Femsa
KOF
$21.6B
| $613K | ﹤0.01% |
14,000
| – | – |
|
|
CCMP
1163
DELISTED
CMC Materials, Inc. Common Stock
CCMP
| $613K | ﹤0.01% |
4,400
+400
| +10% | +$51.8K |
|
1164
Weis Markets
WMK
$1.82B
| $611K | ﹤0.01% |
+12,200
| New | +$612K |
|
1165
Brookdale Senior Living
BKD
$3.62B
| $610K | ﹤0.01% |
206,800
-20,400
| -9% | -$66K |
|
1166
Cue Biopharma
CUE
$135M
| $610K | ﹤0.01% |
830
-110
| -12% | -$79.7K |
|
1167
National Healthcare
NHC
$3.53B
| $609K | ﹤0.01% |
9,600
+800
| +9% | +$53.6K |
|
1168
Q2 Holdings
QTWO
$3.42B
| $609K | ﹤0.01% |
7,100
+1,800
| +34% | +$138K |
|
1169
The Bancorp
TBBK
$2.79B
| $609K | ﹤0.01% |
62,200
-28,000
| -31% | -$211K |
|
1170
e.l.f. Beauty
ELF
$4.56B
| $608K | ﹤0.01% |
31,900
-16,900
| -35% | -$242K |
|
1171
Textron
TXT
$16.6B
| $608K | ﹤0.01% |
18,501
-2,550
| -12% | -$75.3K |
|
|
IMMU
1172
DELISTED
Immunomedics Inc
IMMU
| $606K | ﹤0.01% |
17,106
+3,206
| +23% | +$93.7K |
|
|
BFS
1173
Saul Centers
BFS
$875M
| $605K | ﹤0.01% |
18,771
-153
| -0.8% | -$4.88K |
|
|
ODT
1174
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
| $605K | ﹤0.01% |
14,300
-4,800
| -25% | -$155K |
|
|
CZR
1175
DELISTED
Caesars Entertainment Corporation
CZR
| $605K | ﹤0.01% |
49,946
-42,740
| -46% | -$432K |
|
Similar funds
KK
VAI
UIM
STRS Ohio's Q2 2020 Portfolio in Review
As of Q2 2020, STRS Ohio held 2,333 positions worth $22.9B, up 20% from $19B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
STRS Ohio's Q2 2020 filing shows 311 new, 958 increased, 613 reduced and 176 closed positions. Its largest new stake was RTX Corp: 598,060 shares worth $36.9M. The largest sale was Allergan plc, an estimated $104M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 22% a quarter earlier, followed by Financials and Healthcare.
- STRS Ohio's largest Q2 2020 buy was RTX Corp: 598,060 shares worth $36.9M.
- STRS Ohio added most to Golub Capital BDC in Q2 2020, an estimated $74.9M increase.
- STRS Ohio's biggest Q2 2020 reduction was TransDigm Group, cutting an estimated $43.4M.
- STRS Ohio fully exited Allergan plc in Q2 2020, selling an estimated $104M.
- STRS Ohio's ten largest holdings make up 23% of its $22.9B portfolio in Q2 2020.
- STRS Ohio opened 311 new positions and closed 176 in Q2 2020.
- STRS Ohio's portfolio value rose 20% quarter-over-quarter to $22.9B.
Based on STRS Ohio's 13F filing for Q2 2020, filed 23 Jul 2020.